Sayer H - Search Results

1

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.

Niederwieser D, Lang T, Krahl R, Heinicke T, Maschmeyer G, Al-Ali HK, Schwind S, Jentzsch M, Cross M, Kahl C, Wolf HH, Sayer H, Schulze A, Dreger P, Hegenbart U, Krämer A, Junghanss C, Mügge LO, Hähling D, Hirt C, Späth C, Peter N, Opitz B, Florschütz A, Reifenrath K, Zojer N, Scholl S, Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Müller-Tidow C, Serve H, Schliemann C, Hehlmann R, Berdel WE, Pfirrmann M, Krug U, Hoffmann VS. Niederwieser D, et al. Among authors: sayer h. Ann Hematol. 2023 Mar;102(3):547-561. doi: 10.1007/s00277-023-05087-8. Epub 2023 Jan 25. Ann Hematol. 2023. PMID: 36695874 Free PMC article.

2

Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.

Beelen DW, Quabeck K, Kaiser B, Wiefelspütz J, Scheulen ME, Graeven U, Grosse-Wilde H, Sayer HG, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Transplantation. 1990 Sep;50(3):421-7. doi: 10.1097/00007890-199009000-00013. Transplantation. 1990. PMID: 2402791

3

Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia.

Beelen DW, Quabeck K, Graeven U, Sayer HG, Mahmoud HK, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Blood. 1989 Oct;74(5):1507-16. Blood. 1989. PMID: 2790182 Free article.

4

Allogeneic and autologous bone marrow transplantation in acute leukemia: the Essen Experience.

Schaefer UW, Beelen DW, Graeven U, Kölbel M, Sayer H, Quabeck K, Becher R, Kremens B, Stollmann B, Grosse-Wilde H, et al. Schaefer UW, et al. Among authors: sayer h. Haematol Blood Transfus. 1990;33:649-51. doi: 10.1007/978-3-642-74643-7_117. Haematol Blood Transfus. 1990. PMID: 2323665 No abstract available.

5

Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.

Beelen DW, Haralambie E, Brandt H, Linzenmeier G, Müller KD, Quabeck K, Sayer HG, Graeven U, Mahmoud HK, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Blood. 1992 Nov 15;80(10):2668-76. Blood. 1992. PMID: 1421380 Free article.

6

Clinical results and the Essen concept of TBI.

Molls M, Quast U, Schaefer UW, Szy D, Beelen DW, Quabeck K, Graeven U, Sayer HG, Bamberg M, Sack H. Molls M, et al. Among authors: sayer hg. Radiother Oncol. 1990;18 Suppl 1:121-4. doi: 10.1016/0167-8140(90)90190-8. Radiother Oncol. 1990. PMID: 2247635

7

Bone marrow transplantation for myeloblastoma.

Quabeck K, Beelen DW, Mahmoud HK, Sayer HG, Graeven U, Schaefer UW, Schmidt CG, Hossfeld DK. Quabeck K, et al. Among authors: sayer hg. Eur J Haematol. 1988 Aug;41(2):186-8. doi: 10.1111/j.1600-0609.1988.tb00890.x. Eur J Haematol. 1988. PMID: 3044821

8

Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial.

Beelen DW, Graeven U, Schulz G, Grosse-Wilde H, Doxiadis I, Schaefer UW, Quabeck K, Sayer H, Schmidt CG. Beelen DW, et al. Among authors: sayer h. Onkologie. 1988 Feb;11(1):56-8. doi: 10.1159/000216484. Onkologie. 1988. PMID: 3283628

9

Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemia.

Beelen DW, Quabeck K, Graeven U, Sayer HG, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Haematol Blood Transfus. 1990;33:688-91. doi: 10.1007/978-3-642-74643-7_125. Haematol Blood Transfus. 1990. PMID: 2323667 No abstract available.

10

Very late appearance of acute graft-versus-host disease after tapering immunosuppression.

Wollina U, Sayer HG, Wollina K, Graefe T. Wollina U, et al. Among authors: sayer hg. J Dermatol. 2001 Dec;28(12):734-6. J Dermatol. 2001. PMID: 11804070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters